Posted by Jeffrey Feingold on 07.08.26

Innovation drives growth, and for many businesses, research and development (R&D) investments are a critical part of long-term success. Recent federal tax legislation provided welcome relief by allowing businesses to once again deduct certain research expenses immediately. However, New York State has taken a different path, creating new tax planning and compliance considerations for companies operating within the state

If your business incurs research and experimental (R&E) expenditures and files New York tax returns, understanding these changes is essential to avoid unexpected tax consequences and ensure accurate reporting.

Federal Tax Relief for Research Expenses

Over the past several years, businesses have faced significant changes in how research expenditures are treated for tax purposes. Under prior federal law, many taxpayers were required to capitalize and amortize qualifying Section 174 research expenditures rather than deduct them in the year the costs were incurred. This meant businesses had to spread deductions over multiple years, delaying valuable tax benefits and often increasing taxable income in the short term.

Recent federal legislation reversed course for domestic research activities. Beginning in 2025, qualifying U.S.-based R&E expenditures can once again be deducted immediately for federal tax purposes, providing businesses with faster tax savings and improved cash flow opportunities.

For companies heavily invested in innovation, product development, software creation, engineering, or other research-related activities, the change represents a meaningful financial benefit.

New York Chooses a Different Direction

While federal tax law restored immediate expensing for domestic R&E costs, New York State elected not to fully conform to those provisions. As part of New York’s Fiscal Year 2027 Budget legislation, the state established its own treatment of research expenditures, creating a disconnect between federal and New York tax calculations.

The result is that businesses may now report research expenses differently on their federal and New York tax returns. In many cases, a deduction allowed immediately at the federal level may require a separate adjustment for New York purposes.

These provisions generally apply to tax years beginning on or after January 1, 2025.

What This Means for NY Businesses

The divergence between federal and state tax treatment introduces additional complexity for taxpayers with New York filing obligations.

Businesses may encounter:

• Different taxable income calculations for federal and New York returns
• Additional state-specific modifications and adjustments
• Increased documentation and record keeping requirements
• Greater complexity when preparing tax returns and projections
• Potential amended return considerations for previously filed returns

The impact will vary based on the nature and amount of qualifying research expenditures, as well as the entity's overall tax profile.

Companies with substantial R&D activities including technology firms, manufacturers, life sciences organizations, engineering companies, and startups may experience the most significant effects.

Reviewing Previously Filed Returns

Businesses that have already filed returns for affected tax years should carefully evaluate whether amendments are necessary to comply with New York's updated rules. For taxpayers who have not yet filed, it is important to incorporate the required New York adjustments before submission to minimize potential issues and reduce the likelihood of notices or assessments.

In certain situations, New York has also provided relief from penalties and interest related to these legislative changes. Businesses should review their specific circumstances and determine whether they may qualify for available relief provisions.

Planning Opportunities Moving Forward

The new federal-state disconnect highlights the importance of proactive tax planning.

Organizations with ongoing research activities should consider:

• Reviewing Section 174 expenditures annually
• Tracking federal and New York tax differences separately
• Evaluating the cash-flow impact of varying deduction schedules
• Assessing whether amended returns may provide a tax benefit
• Updating tax forecasts and estimated payment calculations

Maintaining accurate records and understanding how expenses are treated across jurisdictions can help businesses avoid surprises and identify planning opportunities.

Key Points to Remember

New York's decision to diverge from federal R&E expensing rules creates an important distinction that businesses can no longer afford to overlook.

• Qualifying domestic R&E expenditures may be immediately deductible for federal tax purposes beginning in 2025.
• New York has adopted separate rules that may require different treatment of those same expenditures.
• Federal and New York taxable income calculations may no longer align.
• Businesses may need to make additional state-specific tax adjustments.
• Previously filed returns should be reviewed to determine whether amendments or corrections are appropriate.
• Proper planning and documentation will be increasingly important for compliance and tax optimization.

Tax Point Advisors Can Help

Navigating evolving federal and state tax laws can be challenging, especially when certain jurisdictions adopt conflicting rules. Tax Point Advisors works with businesses to evaluate the impact of legislative changes, identify compliance requirements, and develop tax strategies that support growth and innovation.

If your company incurs research and development expenses or has questions about New York's treatment of Section 174 expenditures, our team can help assess your situation and determine the most effective path forward. To learn more about New York’s decision from the experts at Tax Point Advisors, please call us at (800) 260-4138 or please leave us a message below.